Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

The ubiquitin pathway in Parkinson's disease.

Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, Harta G, Brownstein MJ, Jonnalagada S, Chernova T, Dehejia A, Lavedan C, Gasser T, Steinbach PJ, Wilkinson KD, Polymeropoulos MH.

Nature. 1998 Oct 1;395(6701):451-2. No abstract available.

PMID:
9774100
2.

Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants.

Nishikawa K, Li H, Kawamura R, Osaka H, Wang YL, Hara Y, Hirokawa T, Manago Y, Amano T, Noda M, Aoki S, Wada K.

Biochem Biophys Res Commun. 2003 Apr 25;304(1):176-83.

PMID:
12705903
3.
4.

The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease.

Harhangi BS, Farrer MJ, Lincoln S, Bonifati V, Meco G, De Michele G, Brice A, Dürr A, Martinez M, Gasser T, Bereznai B, Vaughan JR, Wood NW, Hardy J, Oostra BA, Breteler MM.

Neurosci Lett. 1999 Jul 23;270(1):1-4.

PMID:
10454131
5.

Intron-exon structure of ubiquitin c-terminal hydrolase-L1.

Leroy E, Boyer R, Polymeropoulos MH.

DNA Res. 1998 Dec 31;5(6):397-400. No abstract available.

6.

Monogenic Parkinsonisms and the genetics of Parkinson's disease.

Bonifati V.

Funct Neurol. 2001 Jan-Mar;16(1):35-44. No abstract available.

PMID:
11396270
7.

The genetics of Parkinson's disease.

de Silva HR, Khan NL, Wood NW.

Curr Opin Genet Dev. 2000 Jun;10(3):292-8. Review.

PMID:
10826990
8.

Genetics of Parkinson's disease.

Polymeropoulos MH.

Ann N Y Acad Sci. 2000;920:28-32. Review.

PMID:
11193165
9.

Genetics of Parkinson's disease and biochemical studies of implicated gene products.

Lansbury PT Jr, Brice A.

Curr Opin Cell Biol. 2002 Oct;14(5):653-60. Review.

PMID:
12231362
10.

cDNA cloning and tissue distribution of a rat ubiquitin carboxyl-terminal hydrolase PGP9.5.

Kajimoto Y, Hashimoto T, Shirai Y, Nishino N, Kuno T, Tanaka C.

J Biochem. 1992 Jul;112(1):28-32.

11.

Parkinson's disease: one biochemical pathway to fit all genes?

Krüger R, Eberhardt O, Riess O, Schulz JB.

Trends Mol Med. 2002 May;8(5):236-40. Review.

PMID:
12067634
12.

Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease.

Maraganore DM, Farrer MJ, Hardy JA, Lincoln SJ, McDonnell SK, Rocca WA.

Neurology. 1999 Nov 10;53(8):1858-60.

PMID:
10563640
13.

Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease.

Lincoln S, Vaughan J, Wood N, Baker M, Adamson J, Gwinn-Hardy K, Lynch T, Hardy J, Farrer M.

Neuroreport. 1999 Feb 5;10(2):427-9.

PMID:
10203348
14.

Genetics of Parkinson's disease and biochemical studies of implicated gene products.

Lansbury PT Jr, Brice A.

Curr Opin Genet Dev. 2002 Jun;12(3):299-306. Review.

PMID:
12076673
15.

Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms.

Momose Y, Murata M, Kobayashi K, Tachikawa M, Nakabayashi Y, Kanazawa I, Toda T.

Ann Neurol. 2002 Jan;51(1):133-6. Erratum in: Ann Neurol 2002 Apr;51(4):534.

PMID:
11782995
16.

Identification and characterization of DEN1, a deneddylase of the ULP family.

Gan-Erdene T, Nagamalleswari K, Yin L, Wu K, Pan ZQ, Wilkinson KD.

J Biol Chem. 2003 Aug 1;278(31):28892-900. Epub 2003 May 19.

17.

Etiology of Parkinson's disease: Genetics and environment revisited.

Steece-Collier K, Maries E, Kordower JH.

Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):13972-4. Epub 2002 Oct 21. Review. No abstract available.

18.

Importance of familial Parkinson's disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson's disease.

Hattori N, Shimura H, Kubo S, Wang M, Shimizu N, Tanaka K, Mizuno Y.

J Neural Transm Suppl. 2000;(60):101-16. Review.

PMID:
11205133
19.

Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases.

Larsen CN, Krantz BA, Wilkinson KD.

Biochemistry. 1998 Mar 10;37(10):3358-68.

PMID:
9521656
20.

Complex interactions in Parkinson's disease: a two-phased approach.

Maraganore DM, de Andrade M, Lesnick TG, Farrer MJ, Bower JH, Hardy JA, Rocca WA.

Mov Disord. 2003 Jun;18(6):631-6.

PMID:
12784265
Items per page

Supplemental Content

Write to the Help Desk